CUREVAC - Trademark Details
Status: 700 - Registered
Serial Number
88602178
Registration Number
6318156
Word Mark
CUREVAC
Status
700 - Registered
Status Date
2021-04-13
Filing Date
2019-09-03
Registration Number
6318156
Registration Date
2021-04-13
Mark Drawing
3000 - Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s)
Typeset
Design Searches
261709 - Curved line(s), band(s) or bar(s).
Published for Opposition Date
2021-01-26
Attorney Name
Law Office Assigned Location Code
M30
Employee Name
MARTIN, LIEF ANDREW
Statements
Certificate of Correction for Registration
In the statement, line 2, "Paul-Ehrlich-Str. 15" should be deleted, and "Friedrich-Miescher-Str. 15" should be inserted.
Indication of Colors claimed
The color(s) orange and blue is/are claimed as a feature of the mark.
Description of Mark
The mark consists of the stylized term "CUREVAC" with the term "CURE" appearing in orange, the term "VAC" appearing in blue, and with a blue curved line beginning at the letter "V", and extending to the right and below the wording.
Goods and Services
Chemical reagents and biomolecules, in particular biological macromolecules, for industrial or scientific purposes; Reagents for research purposes
Goods and Services
Chemical preparations for medical use, namely, for therapeutic and prophylactic treatment of neurological, neuromuscular, neurodegenerative, infectious and cardiovascular diseases, of autoimmune diseases and cancer diseases, of tumours, of allergies, of metabolic diseases, of heritable genetic diseases, and for therapies replacing proteins or enzymes; pharmaceutical preparations, namely, immunostimulants, in particular for human or veterinary medical purposes; pharmaceutical preparations, namely, vaccines, in particular for human or veterinary medical purposes; pharmaceutical preparations, namely, adjuvant immunostimulants; pharmaceuticals and medicaments containing biological macromolecules, in particular for human or veterinary purposes for the treatment of neurological, neuromuscular, neurodegenerative and cardiovascular diseases, for the treatment of infectious diseases, autoimmune diseases and tumours, for treatment of cancers, for treatment of metabolic diseases and for treatment of heritable genetic diseases and for protein or enzyme replacement therapy; gene therapy products, namely, nucleic acid macromolecules for in vivo expression for human or veterinary medical use; Dietetic substances adapted for medical use, in particular substances for food supplements, namely, dietary food supplements; Peptide carrier molecules for association with a biological macromolecule, for medical use, namely, for use in facilitating delivery of a wide range of medicinal substances; Peptidic carrier molecule for preparing a pharmaceutical composition, namely, for medical use as a protein delivery preparation to expedite or improve delivery of a therapeutic macromolecule or prophylactic biological marcomolecule; Peptide carrier molecule, sold in combination with a biological macromolecule for preparing a pharmaceutical composition, namely, for medical use as a protein delivery preparation to expedite or improve delivery of a therapeutic drug or prophylactic drug
Goods and Services
Custom manufacturing of pharmaceutical ingredients, namely, biological macromolecules
Goods and Services
Scientific and technological services and research, in particular scientific research for identification, testing and characterisation of biological macromolecules; medical testing services, namely, pre-clinical and clinical testing of macromolecules; scientific research in the nature of discovery of biological macromolecules; Laboratory services, related to custom manufacturing of pharmaceutical ingredients, for identification, testing and characterisation of biological macromolecules
Goods and Services
Medical and veterinary services, in particular for therapeutic and prophylactic treatment of cancer diseases, infectious diseases, autoimmune diseases or allergies; Medical and veterinary services for treating of hereditary disorders; Medical and veterinary services for protein or enzyme supplement therapy for therapeutic or prophylactic treatment of neurological, neuromuscular, neurodegenerative and cardiovascular diseases and for treatment of endocrinological or metabolic disorders
Pseudo Mark
CURE VAC
Classification Information
International Class
001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins, unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins, unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes
001, 005, 006, 010, 026, 046
Class Status Code
6 - Active
Class Status Date
2019-09-13
Primary Code
001
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2019-09-13
Primary Code
005
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2019-09-13
Primary Code
042
International Class
044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2019-09-13
Primary Code
044
Current Trademark Owners
Party Name
Party Type
30 - Original Registrant
Legal Entity Type
99 - Other (aktiengesellschaft).
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Name
Party Type
30 - Original Registrant
Legal Entity Type
99 - Other (aktiengesellschaft).
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
20 - Owner at Publication
Legal Entity Type
99 - Other (aktiengesellschaft).
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
10 - Original Applicant
Legal Entity Type
99 - Other (aktiengesellschaft).
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Jennifer Fraser
Address
Please log in with your Justia account to see this address.
Foreign Application Information
| Filing Date | Application Number | Country | Foreign Priority Claim In |
| 2019-07-02 | 018089529 | EU | True |
Trademark Events
| Event Date | Event Description |
| 2019-09-06 | NEW APPLICATION ENTERED IN TRAM |
| 2019-09-13 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| 2019-09-14 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| 2019-12-05 | ASSIGNED TO EXAMINER |
| 2019-12-09 | NON-FINAL ACTION WRITTEN |
| 2019-12-09 | NON-FINAL ACTION E-MAILED |
| 2019-12-09 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| 2020-06-04 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 2020-06-15 | ASSIGNED TO LIE |
| 2020-06-16 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 2020-06-16 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 2020-06-30 | NON-FINAL ACTION WRITTEN |
| 2020-06-30 | NON-FINAL ACTION E-MAILED |
| 2020-06-30 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| 2020-12-15 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 2020-12-16 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 2020-12-16 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 2020-12-17 | EXAMINERS AMENDMENT -WRITTEN |
| 2020-12-17 | EXAMINERS AMENDMENT E-MAILED |
| 2020-12-17 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| 2020-12-17 | EXAMINER'S AMENDMENT ENTERED |
| 2020-12-17 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 2021-01-06 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 2021-01-26 | PUBLISHED FOR OPPOSITION |
| 2021-01-26 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 2021-04-13 | REGISTERED-PRINCIPAL REGISTER |
| 2021-04-30 | TEAS SECTION 7 REQUEST RECEIVED |
| 2021-09-30 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| 2021-09-30 | CORRECTION UNDER SECTION 7 ¿ PROCESSED |
